| Application no. and date | 99910359.1 (espacenet) (Federated) (European Patent Register), 19990318 | | Patent/reg. no. and date | DK/EP 1033978, 20011219 | | Publication date | 20000913 | | Priority no. and date | DE 19814084, 19980330 | | EP pub. no. and date |
EP 1033978 20000913 | | Effective date | | | Applicant/owner | LTS Lohmann Therapie-Systeme AG, Lohmannstrasse 2
56626 Andernach, DE,
UCB Biopharma SRL, Allée de la Recherche 60
1070 Brussels, BE | | Applicant ref. no. | 74301 | | Inventor | MÜLLER, Walter, Engerser Strasse 56
D-56564 Neuwied, DE,
PECK, James, V., 10821 Millington Lane
Richmond, VA 23233, US | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | | Opponent | | | IPC Class | A61K 9/70 | | Title | Transdermalt terapeutisk system indeholdende D2-agonist til behandling af Parkinson-syndrom og fremgangsmåde til fremstilling deraf | | Int. application no. | PCT/EP99/01795 | | Int. publication no. | WO99049852 | | Related patent (certificate) | CA 2006 00020 | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
